Dr Amayiri is a neuro-oncologist at the King Hussein Cancer Center (KHCC) in Jordan. She completed her Higher Specialization in Pediatrics at the Jordan University of Science & Technology and her fellowship in Pediatric Hematology/Oncology at the KHCC. Following her graduation in 2011, she was appointed and continues to be in charge of the neuro-oncology service. Dr. Amayiri is the recipient of the ASCO 2016 Life Award from the Conquer Cancer Foundation which enabled her to pursue her pediatric Neuro-Oncology fellowship at the Hospital for Sick Children (Sickkids)/Toronto in 2016/2017. 
Dr. Amayiri has several publications related to pediatric brain tumors. Her main clinical interest is to work nationally, regionally and internationally to improve the survival and importantly the quality of life of children diagnosed with CNS tumors in resource-limited countries. She believes that this can be achieved through close collaborations and twinning with institutions and programs in high income countries

Academic Titles / Tasks:  Professor, 2022 - continues, Ankara Yildirim Beyazit University, Faculty of Medicine, Surgical Medical Sciences
Associate Professor, 2019 - 2022, Ankara Yildirim Beyazit University, Faculty of Medicine, Surgical Medical Sciences
Associate Professor, 2017 - 2022
Others, Ankara Child Disease Hematology and Oncology Education and Research Hospital, 2010-2019
Awards
1. Azılı M. N., 2016 Prof. Dr. İhsan Numanoğlu Scientific Research Award, 34th National Pediatric Surgery Congress, October 2016.

Dr. Yonca Bulut is a Professor of Pediatrics at The David Geffen School of Medicine at UCLA. She is the medical director of Pediatric ICU at UCLA Mattel Children’s Hospital. She received her medical degree from the University of Ankara, Turkiye. She completed her residency in pediatrics at Children's Hospital Medical Center of Akron in Ohio and her pediatric critical care fellowship training at the Johns Hopkins Hospital. Dr Yonca Bulut’s research interests include sepsis, diseases of iron overload and role of iron in infection. She is the recipient of national and private grants such as NIH KO8, Today’s Tomorrow’s Children’s Fund and Oppenheimer Grant.  

Dr. Pelin Cengiz’s research focuses on finding a novel therapy for neonatal encephalopathy subsequent to hypoxia ischemia (HI). She uses the experimental (Vannucci-Rice) mouse model of hypoxia ischemia (HI) to study the sexually differentiated role of neurotrophin signaling in the neonatal hippocampus post-HI. The neurotrophin receptor, tyrosine kinase B (TrkB), plays an important role in neuroprotection and improving the long-term functional recovery following cerebral ischemia by increasing neuronal survival. She has shown that administration of 7,8 dihydroxyflavone (7,8-DHF; potent and selective TrkB agonist) increases TrkB phosphorylation and hippocampal neuronal survival following HI in female, but not in male newborn mice. This female-specific responsiveness to TrkB agonist therapy mimics improved outcomes observed clinically in female newborn humans post-HI. Her studies focus on the cellular mechanisms of the female-specific responsiveness to TrkB agonist and their roles in improving long-term neurological and functional outcome post-HI. An improved understanding of the cellular mechanisms that underlie sex-specific neurotrophin responses will identify new avenues for developing novel therapeutics for neonates and children suffering from brain injury.

Dr. Cengiz’s clinical duties include serving as an Attending in the PICU and in the Outpatient Sedation Clinic at American Family Children’s Hospital. Abroad, she is an active member of the international health community.

Malatya, 1972 yılı doğumludur. İlk ve orta öğrenimini İzmir'de tamamladı.  İnönü Üniversitesi Tıp Fakültesi'nden 1995 yılında mezun oldu. Adnan Menderes ÜTF'nde Radyodiasnotik AD'nda radyoloji uzmanlığı eğitimi aldı. Celal Bayar TF Pediatrik Radyoloji BD'nda, 2018 yılında yan dal eğitimini tamamladı. Konya Meram EAH ve Konya Şehir Hastanesi'nde 2 yıl çalıştıktan sonra, 2021 yılında Ankara Bilkent ŞH Çocuk Radyolojisi Bölümü'nde ya dal uzmanı olarak görev aldı. Bu kurumda 2022 yılında radyoloji doçenti ünvanı aldı. Aynı yıl içinde Sağlık Bilimleri Üniversitesi Gülhane Tıp Fakültesi Radyoloji AD'na eğitim görevlisi olarak atandı. Bu tarihten itibaren Ankara Bilkent ŞH Çocuk Radyolojisi Bölümü Eğitim ve İdari Sorumlusu olarak görevine devam etmektedir. 

Dr. Enrico Lombardi, MD graduated in Medicine from the University of Florence, Italy, in 1991. From 1995 to 1996 he was a research associate in Tucson, Arizona, where he worked and published in the fields of lung function testing in young children and the epidemiology of pediatric asthma. He completed his residency in Pediatrics in 1997 in Florence, in 2001 he took a position as Pediatrician at the Meyer Children’s Hospital. In 2006 he completed the specialization in Diseases of the Respiratory System and since then he is in charge of the Pediatric Pulmonary Unit at Meyer Children’s Hospital. Dr. Lombardi was the chair of the 7.1 Group “Pediatric Respiratory Physiology and Sleep” of the European Respiratory Society from 2012 to 2015 and chair of the International Relation Committee of the Pediatric Assembly of the American Thoracic Society from 2010 to 2016. His main area of interest is lung function testing in young children, on which he has published extensively and presented nationally and internationally. He is the current vice-president (2024-2026) of the Italian Pediatric Respiratory Society/Società Italiana Malattie Respiratorie Infantili (IPRS/SIMRI).